1-10 of 10
Ricky W Johnstone, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Different Classes of ABL1 Fusions Activate Different Downstream Signalling Nodes

Lauren M Brown, BSc, Hannah Huckstep, BSc, Jarrod Sandow, PhD, Ray C Bartolo, PhD, Nadia Davidson, PhD, Breon Schmidt, BSc, Stefan Bjelosevic, BSc, Ricky W Johnstone, PhD, Alicia Oshlack, PhD, Melissa Davis, PhD, Paul G Ekert
Journal: Blood
Blood (2018) 132 (Supplement 1): 2628.
https://doi.org/10.1182/blood-2018-99-117844
Published: 2018
Journal Articles

BCOR Regulates Cell Fate Transition, Myeloid Differentiation and Leukaemogenesis

Lev M Kats, PhD, Madison J Kelly, Gareth Gregory, MBBS, PhD FRACP, FRCPA, Ricky W Johnstone, PhD, Stephin J Vervoort, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3907.
https://doi.org/10.1182/blood-2018-99-117893
Published: 2018
Journal Articles

Intravital Microscopy Reveals Fundamental Differences in the Interaction of Stem Cells and T Acute Lymphoblastic Leukaemia with the Bone Marrow Microenvironment

Cristina Lo Celso, PhD, Edwin D Hawkins, PhD, Delfim Duarte, MD, Olufolake Akinduro, PhD, Reema A Khorshed, PhD, Diana Passaro, PhD, Malgorzata Nowicka, Lenny Straszkowski, Mark K Scott, Steve Rothery, Nicola Ruivo, Katie Foster, Michaela Waibel, Ricky W Johnstone, PhD, Simon J. Harrison, David A Westerman, MBBS, FRACP, FRCPA, Hang Quach, MBBS (Hons), FRACP, FRCPA, MD, John Gribben, Mark D Robinson, Louise E Purton, PhD, Dominique Bonnet, PhD
Journal: Blood
Blood (2016) 128 (22): 5199.
https://doi.org/10.1182/blood.V128.22.5199.5199
Published: 2016
Journal Articles

Bigger, Stronger, Faster: Chimeric Antigen Receptor T Cells Are Olympic Killers

Paul J Neeson, BSc, PhD, Alexander James Davenport, BSC, MSc, Joseph A Trapani, Michael Kershaw, PhD, Ryan Cross, H. Miles Prince, MD PhD, Ricky W Johnstone, PhD, David Ritchie, MD PhD, Phil Darcy, Misty R Jenkins
Journal: Blood
Blood (2016) 128 (22): 814.
https://doi.org/10.1182/blood.V128.22.814.814
Published: 2016
Journal Articles

Modelling Resistance to Emerging Epigenetic Therapies

Chun Yew Fong, MBBS FRACP FRCPA, Omer Gilan, PhD, Enid Lam, PhD, Alan Rubin, PhD, Jessica Morison, PhD, George Giotopoulos, PhD, Kym Stanley, Ftouni Sarah, MSc, Dean Tyler, Dave Lugo, Philip Jeffrey, Richard Gregory, Jaring Schreuder, Shalin Naik, PhD, Tony Kouzarides, PhD, Brian Huntly, MD PhD, Ricky W Johnstone, PhD, Rab K Prinjha, Anthony Papenfuss, PhD, Mark A Dawson, MBBS FRACP FRCPA PhD
Journal: Blood
Blood (2014) 124 (21): 3546.
https://doi.org/10.1182/blood.V124.21.3546.3546
Published: 2014
Journal Articles

Class I/II Histone Deacetylase Inhibitors Are a Potential Therapeutic For Notch-1 Driven T Cell Acute Lymphoblastic Leukemia

Michaela Waibel, PhD, Edwin D Hawkins, PhD, Kelly M Ramsbottom, Benjamin P Martin, Ricky W Johnstone, PhD
Journal: Blood
Blood (2013) 122 (21): 1435.
https://doi.org/10.1182/blood.V122.21.1435.1435
Published: 2013
Journal Articles

Inhibition Of RNA Polymerase I Transcription By CX-5461 As a Therapeutic Strategy For The Cancer-Specific Activation Of p53 In Highly Refractory Haematological Malignancies

Nadine Hein, PhD, Sean O'Brien, Ph.D., Denis Drygin, PhD, Simon J. Harrison, MBBS MRCP (uk) MRCPath (uk) PhD, Amit Khot, MD, FRCPath, MBBS, MRCP, Carleen Cullinane, PhD, Matthews Geoff, PhD, Marta Chesi, PhD, Peter Leif Bergsagel, MD, Johannes Zuber, MD, Scott W. Lowe, Ph.D., Ricky W Johnstone, PhD, Rick Pearson, PhD, Grant A. McArthur, MD, PhD, FRACP, MBBS, Ross D Hannan, PhD
Journal: Blood
Blood (2013) 122 (21): 3941.
https://doi.org/10.1182/blood.V122.21.3941.3941
Published: 2013
Journal Articles

The Pan Histone Deacetylase Inhibitor Panobinostat and the Iso-Selective Inhibitor Romidepsin Reduce Glycoprotein VI Expression and Inhibit Platelet Activation in Response to Collagen Related Peptide

Mark J Bishton, Miles Prince, MD, FRACP, FRCPA, Ricky W Johnstone, PhD, Simon J. Harrison, MBBS MRCP (uk) MRCPath (uk) PhD, Benjamin T. Kile, PhD
Journal: Blood
Blood (2011) 118 (21): 1154.
https://doi.org/10.1182/blood.V118.21.1154.1154
Published: 2011
Journal Articles

Inhibition of RNA Polymerase I Transcription by CX-5461 As a Therapeutic Strategy for the Cancer-Specific Activation of p53 in MLL-Rearranged Acute Myeloid Leukemias

Nadine Hein, PhD, Megan J Bywater, PhD, Kim Stanley, BSc, Inge Verbrugge, PhD, Carlene Cullinane, PhD, Adele Baker, PhD, Hannes Zuber, PhD, Amy Rappaport, PhD, Denis Drygin, PhD, Nanni Huser, PhD, Josh Bliesath, PhD, David M Ryckman, PhD, William G Rice, PhD, Scott W Lowe, PhD, Ricky W Johnstone, PhD, Richard B Pearson, PhD, Grant A. McArthur, MD, PhD, FRACP, MBBS, Ross D Hannan, PhD
Journal: Blood
Blood (2011) 118 (21): 1548.
https://doi.org/10.1182/blood.V118.21.1548.1548
Published: 2011
Journal Articles

N-Methyl-2-Pyrrolidone Is a Biologically Active Thalidomide Subunit with In Vivo anti-Myeloma Properties

Jake Shortt, FRACP, FRCPA, Andy Hsu, PhD, Geoffrey M Matthews, PhD, Marta Chesi, P.Leif Bergsagel, MD, Grant A. McArthur, MD, PhD, FRACP, MBBS, Paul Neeson, PhD, David Ritchie, MBBS, FRACP, FRCPA, Ricky W Johnstone, PhD
Journal: Blood
Blood (2010) 116 (21): 4082.
https://doi.org/10.1182/blood.V116.21.4082.4082
Published: 2010